BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17084680)

  • 1. Validation of XP-C pathogenic variations in archival material from a live XP patient.
    McDaniel LD; Rivera-Begeman A; Doughty AT; Schultz RA; Friedberg EC
    DNA Repair (Amst); 2007 Jan; 6(1):115-20. PubMed ID: 17084680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel XPC pathogenic variant detected in archival material from a patient diagnosed with Xeroderma Pigmentosum: a case report and review of the genetic variants reported in XPC.
    Rivera-Begeman A; McDaniel LD; Schultz RA; Friedberg EC
    DNA Repair (Amst); 2007 Jan; 6(1):100-14. PubMed ID: 17079196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus.
    Armelini MG; Muotri AR; Marchetto MC; de Lima-Bessa KM; Sarasin A; Menck CF
    Cancer Gene Ther; 2005 Apr; 12(4):389-96. PubMed ID: 15650764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of matrix metalloproteinase 1 in dermal fibroblasts from DNA repair-deficient/cancer-prone xeroderma pigmentosum group C patients.
    Fréchet M; Warrick E; Vioux C; Chevallier O; Spatz A; Benhamou S; Sarasin A; Bernerd F; Magnaldo T
    Oncogene; 2008 Sep; 27(39):5223-32. PubMed ID: 18469853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations.
    Schäfer A; Hofmann L; Gratchev A; Laspe P; Schubert S; Schürer A; Ohlenbusch A; Tzvetkov M; Hallermann C; Reichrath J; Schön MP; Emmert S
    Exp Dermatol; 2013 Jan; 22(1):24-9. PubMed ID: 23173980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of nucleotide excision repair defects between XPD-mutated fibroblasts derived from trichothiodystrophy and xeroderma pigmentosum patients.
    Nishiwaki T; Kobayashi N; Iwamoto T; Yamamoto A; Sugiura S; Liu YC; Sarasin A; Okahashi Y; Hirano M; Ueno S; Mori T
    DNA Repair (Amst); 2008 Dec; 7(12):1990-8. PubMed ID: 18817897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC.
    Sands AT; Abuin A; Sanchez A; Conti CJ; Bradley A
    Nature; 1995 Sep; 377(6545):162-5. PubMed ID: 7675084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels.
    Chavanne F; Broughton BC; Pietra D; Nardo T; Browitt A; Lehmann AR; Stefanini M
    Cancer Res; 2000 Apr; 60(7):1974-82. PubMed ID: 10766188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C.
    Zeng L; Quilliet X; Chevallier-Lagente O; Eveno E; Sarasin A; Mezzina M
    Gene Ther; 1997 Oct; 4(10):1077-84. PubMed ID: 9415314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional lentiviral vectors for xeroderma pigmentosum gene therapy.
    Marchetto MC; Correa RG; Menck CF; Muotri AR
    J Biotechnol; 2006 Dec; 126(4):424-30. PubMed ID: 16857285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
    Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
    Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene transduction in skin cells: preventing cancer in xeroderma pigmentosum mice.
    Marchetto MC; Muotri AR; Burns DK; Friedberg EC; Menck CF
    Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17759-64. PubMed ID: 15598745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced capacity to repair irradiated adenovirus in fibroblasts from xeroderma pigmentosum heterozygotes.
    Rainbow AJ
    Cancer Res; 1980 Nov; 40(11):3945-9. PubMed ID: 7471045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of xeroderma pigmentosum (XP); variability and stability within and between the complementation groups C, D, E, I and variants.
    Jung EG; Bohnert E; Fischer E
    Photodermatol; 1986 Jun; 3(3):125-32. PubMed ID: 3748852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Xeroderma pigmentosum].
    Takeuchi S
    Nihon Rinsho; 2000 Jul; 58(7):1496-500. PubMed ID: 10921330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xeroderma pigmentosum genes: functions inside and outside DNA repair.
    Sugasawa K
    Carcinogenesis; 2008 Mar; 29(3):455-65. PubMed ID: 18174245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensitivity of primary human fibroblasts with defective unhooking of DNA interstrand cross-links.
    Clingen PH; Arlett CF; Hartley JA; Parris CN
    Exp Cell Res; 2007 Feb; 313(4):753-60. PubMed ID: 17188678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.
    Itoh T
    J Dermatol Sci; 2006 Feb; 41(2):87-96. PubMed ID: 16325378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal regulation of DDB2 gene expression in xeroderma pigmentosum group E strains.
    Itoh T; Nichols A; Linn S
    Oncogene; 2001 Oct; 20(48):7041-50. PubMed ID: 11704828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic complementation group analysis of xeroderma pigmentosum patients in China].
    Qiang K; Zhang Y; Han Z; You Y; Jiao H; Xu F; Xu P; Sun L; Ho Z; Peng L; Yu Z; Ikenage M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Oct; 16(5):285-9. PubMed ID: 10514532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.